| Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108) |
|---|
| 03/03/2009 | US7498356 Substituted amino carboxylic acids |
| 03/03/2009 | US7498349 To treat Gram-positive bacterial infections; antibacterial and/or antifungal properties; Preferably drug-resistant strains of bacteria |
| 02/26/2009 | WO2009025328A1 Ascorbic acid derivative or salt thereof, method for producing the same, and cosmetic preparation |
| 02/26/2009 | WO2009024550A1 N-benzyl, n' -arylcarbonylpiperazine derivatives as lxr modulators |
| 02/26/2009 | WO2008152217A3 Process for preparing 2-(n-butyl)-5-nitrobenzofuran |
| 02/26/2009 | WO2008024439A3 4-aminoquinazoline derivatives and methods of use thereof |
| 02/26/2009 | US20090054514 (3-Amino-6-phenyl-benzofuran-2-yl)-(2,4-dichloro-phenyl)-methanone; antiprolifrative, anticarcinogenic, antitumor agent; lymphomas, sarcomas, and leukemias |
| 02/26/2009 | US20090054448 Amino Acid Derivatives as Histone Deacetylase (HDAC) Inhibitors |
| 02/26/2009 | US20090054376 Benzofuran derivatives with therapeutic activities |
| 02/26/2009 | US20090054240 Heteroaroyl-substituted Alanines |
| 02/26/2009 | US20090054235 Benzoheterocyclylethylbenzamide derivatives |
| 02/26/2009 | US20090053826 Electropolymerisable monomers that are soluble in aqueous solution and electroactive probes that can be obtained with such monomers |
| 02/26/2009 | US20090053780 Enzymatic oxidation of HMF |
| 02/26/2009 | US20090053710 Functional molecule, functional molecule synthesizing amidite and target substance analysis method |
| 02/26/2009 | US20090053175 Substitute pyrrolidine derivatives |
| 02/26/2009 | CA2694604A1 N-benzyl, n' -arylcarbonylpiperazine derivatives as lxr modulators |
| 02/25/2009 | EP2027102A2 PRODUCTION OF PHTHALIC ANHYDRIDE BY GAS PHASE OXIDATION OF o-XYLOL IN A PRIMARY AND A SECONDARY REACTOR |
| 02/25/2009 | EP2027101A1 Trisubstituted furan derivatives as fragrances and aroma substances |
| 02/25/2009 | EP2027100A2 Cyclic hydrofluoroether compounds and processes for their preparation and use |
| 02/25/2009 | EP2027087A2 Intracellular kinase inhibitors |
| 02/25/2009 | EP2026825A2 Furanone-initiated polymers |
| 02/25/2009 | EP1856031B1 2-arylpropionic acid derivatives and pharmaceutical compositions containing them |
| 02/25/2009 | EP1824921B1 Lactone stabilizing compositions |
| 02/25/2009 | EP1143965B1 Carbocyclic potassium channel inhibitors |
| 02/25/2009 | CN101374806A Method for producing methionine from homoserine |
| 02/25/2009 | CN101371986A Method for preparing Cu-Cr metallic oxide with high specific surface area and application |
| 02/25/2009 | CN100463905C Method for producing maleic anhydride of hydriding terpene |
| 02/24/2009 | US7495027 drugs that inhibit biosynthesis of bacterial cell walls, such as (5Z)-5-[(3',5'-dichloro-1,1'-biphenyl-3-yl)methylene]-3-(3,5-dichlorophenyl)-4-hydroxyfuran-2(5H)-one, used for treatment of bacterial infections, and as parasiticides |
| 02/24/2009 | US7495024 Use of e.g. N-[3-[5-[(4-fluorophenyl)methyl]-2-thienyl]-1-methyl-2-propynyl]-N-hydroxyurea (ABT-761, Atreleuton) |
| 02/24/2009 | US7495023 treat protozoan infections such as trypanosomiasis, malaria and leishmaniasis; also inhibiting cathepsins B and L to treat cancer; e.g. 3'-Bromopropiophenone Thiosemicarbazone |
| 02/24/2009 | US7495017 3-(3-Cyclopentyloxy-4-methoxyphenyl)-1H-pyrazole;adenosine monophosphate activator; antiinflammatory agent, antidepressant, antiallergen, cognition activator, neurodegenerative diseases; arthritis, Alzheimer's disease, schizophrenia, Parkinson disease |
| 02/24/2009 | US7494990 2-(piperidin-4-yl)-4,5-dihydro-2H-pyridazin-3-one derivatives as PDE4 inhibitors |
| 02/24/2009 | CA2339597C Anti-inflammatory analgesic preparations comprising 3-o-ascorbic acid derivatives |
| 02/19/2009 | WO2009022720A1 Five-membered heterocyclic compound |
| 02/19/2009 | WO2009022633A1 Bicyclic acylguanidine derivative |
| 02/19/2009 | WO2009022311A2 1,2-diamido-ethylene derivatives as orexin antagonists |
| 02/19/2009 | WO2009021740A2 Substituted tetrahydronaphthalenes, process for the preparation thereof and the use thereof as medicaments |
| 02/19/2009 | WO2008148376A3 Method for producing phthalic anhydride from reaction gases |
| 02/19/2009 | US20090048458 Synthesis of 2-hydroxy-n,n-dimethyl-3-[[2-[[1(r)-(5-methyl-2-furanyl)propyl]amino]-3,4-dioxo-1-cyclobuten-1-yl]amino]benzamide |
| 02/19/2009 | US20090048336 Escitalopram oxalate powders |
| 02/19/2009 | US20090048330 Compound from Antrodia camphorata and the use thereof |
| 02/19/2009 | US20090048325 Prophylactic or Therapeutic Agent for Irritable Bowel Syndrome |
| 02/19/2009 | US20090048255 Phosphodiesterase 4 inhibitors, including n-substituted aniline and diphenylamine analogs |
| 02/19/2009 | US20090048224 Compounds and methods of use |
| 02/19/2009 | CA2695955A1 Novel substituted tetrahydronaphthalenes, process for the preparation thereof and the use thereof as medicaments |
| 02/19/2009 | CA2695878A1 5-membered heterocyclic compound |
| 02/19/2009 | CA2695636A1 Bicyclic acylguanidine derivative |
| 02/19/2009 | CA2694993A1 1,2-diamido-ethylene derivatives |
| 02/18/2009 | EP2025674A1 Substituted tetra hydro naphthalines, method for their manufacture and their use as drugs |
| 02/18/2009 | EP2024506A1 Method for reducing impurity level in mycophenolic acid fermentation |
| 02/18/2009 | EP2024351A1 Production of phthalic anhydride by gas phase oxidation of o-xylol |
| 02/18/2009 | EP2024330A1 Production method of heterocyclic mercapto compound |
| 02/18/2009 | EP2024310A1 Materials for organic electroluminescent devices |
| 02/18/2009 | EP2024085A1 Catalyst system for the manufacture of carboxylic acids and/or carboxylic acid anhydrides |
| 02/18/2009 | EP1853577A4 Improved process for preparing (disubstitutedpropenyl) phenylalkyl substituted dihydrobenzofurans |
| 02/18/2009 | EP1716091B1 Method for producing optically active alcohols or carboxylic acids |
| 02/18/2009 | EP1614684B1 Diamine derivative, production process, and antioxidizing drug |
| 02/18/2009 | EP1399431B1 Novel nitriles useful as reversible inhibitors of cysteine proteases |
| 02/18/2009 | EP1084137B1 Peptide inhibitors of hepatitis c virus ns3 protease |
| 02/18/2009 | EP1017674B1 Utilizing spirocyclic phenyl keto-enols as pesticides and herbicides |
| 02/18/2009 | CN101370773A Cycloalkanecarboxamide derivative and method for producing same |
| 02/18/2009 | CN101367799A Matrine salviol acid B complex salt and kuh-seng native salviol acid B complex salt, preparation method and application thereof |
| 02/18/2009 | CN101367784A Vinyl cyanide compounds, preparation and application thereof |
| 02/18/2009 | CN101367783A Preparation method of 5-hydroxymethyl furfural |
| 02/18/2009 | CN101367782A Method for preparing 5-hydroxymethyl furfural by catalyzing glucose with solid ultra-strong acid |
| 02/18/2009 | CN101367781A 2-(1,1-dibromo-2-allyl) furfuran and synthesis thereof |
| 02/18/2009 | CN101367780A Joint production method for (S)-3-hydroxyl-gamma-butyrolactone, (S)-3-hydroxyl tetrahydrofuran |
| 02/18/2009 | CN101367712A Polysubstituted decahydronaphthalene compound, synthesis method and uses thereof |
| 02/18/2009 | CN101367041A Preparation of solid base catalyst, uses of the same in hydroxide aldehyde condensation reaction |
| 02/18/2009 | CN100462354C Novel 1,2-diphenylethene derivatives for treatment of immune diseases |
| 02/18/2009 | CN100462352C Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
| 02/17/2009 | US7491747 4-(Arylthio)- or (4-heteroarylthio)butyric acid derivatives that may be used in the treatment of dyslipidaemia, atherosclerosis and diabetes |
| 02/17/2009 | US7491741 Diaminopropionic acid derivatives |
| 02/17/2009 | US7491733 Bicyclic guanidine derivatives and therapeutic uses thereof |
| 02/17/2009 | US7491723 Alkanol and cycloalkanol-amine derivatives and methods of their use |
| 02/17/2009 | US7491705 ((1S)-1-((((1S)-1-benzyl-2,3-dioxo-3-(cyclopropylamino)propyl)amino)carbonyl)-3-methylbutyl)carbamic acid 5-methoxy-3-oxapentyl ester; ischemic disease, immunologic disease, multiple sclerosis, Alzheimer's disease, osteoporosis, diseases caused by brain tissue damage, cataract, glaucoma |
| 02/17/2009 | US7491245 Carbazole and dibenzofuran dyes: 3-(1-amino-9-methyl-9H-carbazol-4-ylamino)-propan-1-ol, dibenzofuran-1,4-diamine; can act as both developers and couplers |
| 02/12/2009 | WO2009021126A2 Benzo-fused thiophene or benzo-fused furan compounds comprising a triphenylene group |
| 02/12/2009 | WO2009018780A1 Andrographolide derivatives and use thereof in manufacture of medicaments |
| 02/12/2009 | US20090043117 Process For Preparing (Disubstitutedpropenyl) Phenylalkyl Substituted Dihydrobenzofurans |
| 02/12/2009 | US20090043116 Hetero-polycyclic compounds, and coloring matters, pigments, dyes, color-changing material compositions, and color-changing films, made by using the compounds |
| 02/12/2009 | US20090043114 Flow reactors for chemical conversions with heterogeneous catalysts |
| 02/12/2009 | US20090043108 reacting dicholoro-o-xylene with Sodium hydroxymethanesulfinate in dimethylsulfoxide solvent in presence of NaI and K2CO3 base to form sultine, reacting sultine with maleic anhydride to form tetrahydronaphthalic anhydride as a Diels-Alder adduct, aprecursor for naphthalocyanine via benzisoindolenine |
| 02/12/2009 | US20090042977 Anticancer Compound, Intermediate Therefor, and Processes for Producing These |
| 02/12/2009 | US20090042973 Inhibitors of aspartyl protease |
| 02/12/2009 | US20090042929 11-Beta-Hydroxysteroid Dehydrogenase Inhibitors |
| 02/12/2009 | US20090042920 Carbonylamino-derivatives as novel inhibitors of histone deacetylase |
| 02/12/2009 | US20090042875 Substituted heterocyclic compounds and uses thereof |
| 02/12/2009 | US20090042866 Tetrahydrocarbazoles as Active Agents for Inhibiting VEGF Production by Translational Control |
| 02/12/2009 | US20090042861 Prophylactic or Therapeutic Agent for Depression or Anxiety Disorder |
| 02/12/2009 | US20090042114 Halogenated oxime derivatives and the use therof as latent acids |
| 02/11/2009 | EP2021332A2 Mercaptofunctional high "mu-beta" eo chromophores and high tg, low optical loss, covalently bonded, polymers containing said chromophores and methods of synthesizing eo materials |
| 02/11/2009 | EP2021329A1 Inhibitors of c-fms kinase |
| 02/11/2009 | EP2021327A2 Antidiabetic bicyclic compounds |
| 02/11/2009 | CN101362743A Intermediates for the preparation of citalopram and escitalopram |
| 02/11/2009 | CN101362742A Structure modified outcome of salvianolic acid B and preparation method thereof |
| 02/11/2009 | CN101362741A Structure modified salvianolic acid B derivates and synthesis method thereof |
| 02/11/2009 | CN101362740A Method for synthesizing andrographolide sodium bisulfite |
| 02/11/2009 | CN101362714A 2-heterocycle(C-C bond)-4-oxobutanoate and preparation method thereof |
| 02/11/2009 | CN100460401C Process for synthesizing bibenzene tetracarboxylic dianhydride |